Hsa-miR-105-5p acts as an oncogene in triple-negative breast cancer
Da Qian,
Tao Zhou,
Hanchu Xiong,
Yuhao Xu,
Jie Qiu,
Yihao Wu,
Weimin Hong,
Xuli Meng,
Yanjie Yin
Affiliations
Da Qian
1 Department of Burn and Plastic Surgery-Hand Surgery, The Changshu Hospital Affiliated to Soochow University, Changshu, Jiangsu 215000, China
Tao Zhou
2 Faculty of Basic Medicine, Hangzhou Medical College, Hangzhou, Zhejiang 310014, China
Hanchu Xiong
3 Cancer Center, Department of Radiation Oncology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang 314408, China
Yuhao Xu
4 Second Clinical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310014, China
Jie Qiu
4 Second Clinical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310014, China
Yihao Wu
5 College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou, Zhejiang 310014, China
Weimin Hong
2 Faculty of Basic Medicine, Hangzhou Medical College, Hangzhou, Zhejiang 310014, China
Xuli Meng
6 Cancer Center, Department of Breast Surgery, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, Zhejiang 314408, China.
